Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Wiese Edward A

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/21/2015

3. Issuer Name and Ticker or Trading Symbol

PRICE T ROWE GROUP INC [TROW]

(Last) (First) (Middle)

T. ROWE PRICE GROUP, INC., 100 E. PRATT STREET

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Vice President /

(Street)

BALTIMORE, MD 21202

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	140640.301	D
Common Stock	12281	I	Spouse
Common Stock	76000.277	I	Wiese EA Family 2012 Trust
Common Stock	38000	I	Wiese RJ Family 2012 Trust
Common Stock	38000	I	Wiese WS Family 2012 Trust

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	⁽¹⁾	10/3/2015	Common Stock	3046	$32.118	D
Stock Options (Right to Buy)	⁽²⁾	11/1/2016	Common Stock	10155	$45.4792	D
Stock Options (Right to Buy)	⁽³⁾	9/6/2017	Common Stock	8124	$49.2503	D
Stock Options (Right to Buy)	⁽⁴⁾	9/4/2018	Common Stock	7109	$56.2017	D
Stock Options (Right to Buy)	⁽⁵⁾	2/12/2019	Common Stock	1645	$27.0473	D
Stock Options (Right to Buy)	⁽⁶⁾	9/10/2019	Common Stock	4061	$44.4552	D
Stock Options (Right to Buy)	⁽⁷⁾	2/18/2020	Common Stock	6092	$48.8368	D
Stock Options (Right to Buy)	⁽⁸⁾	9/8/2020	Common Stock	6093	$46.9365	D
Stock Options (Right to Buy)	⁽⁹⁾	2/17/2021	Common Stock	6093	$69.2478	D
Stock Options (Right to Buy)	⁽¹⁰⁾	9/8/2021	Common Stock	6092	$49.7721	D
Stock Options (Right to Buy)	⁽¹¹⁾	2/23/2022	Common Stock	3046	$60.5438	D
Stock Options (Right to Buy)	⁽¹²⁾	9/6/2022	Common Stock	3046	$62.3161	D
Stock Options (Right to Buy)	⁽¹³⁾	2/21/2023	Common Stock	3000	$71.41	D
Stock Options (Right to Buy)	⁽¹⁴⁾	9/10/2023	Common Stock	3000	$72.04	D
Stock Options (Right to Buy)	⁽¹⁵⁾	2/19/2024	Common Stock	3000	$79.89	D
Stock Options (Right to Buy)	⁽¹⁶⁾	9/9/2024	Common Stock	3000	$80.40	D

Explanation of Responses:
( 1)	10/03/2005 Grant - The option vests 20% annually over a 5 year period beginning on 10/03/2006.
( 2)	11/01/2006 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2007.
( 3)	09/06/2007 Grant - The option vests 20% annually over a 5 year period beginning on 09/06/2008.
( 4)	09/04/2008 Grant - The option vests 20% annually over a 5 year period beginning on 09/04/2009.
( 5)	02/12/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.
( 6)	09/10/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.
( 7)	02/18/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.
( 8)	09/08/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.
( 9)	02/17/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.
( 10)	09/08/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.
( 11)	02/23/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.
( 12)	09/06/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.
( 13)	02/21/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.
( 14)	09/10/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.
( 15)	02/19/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.
( 16)	09/09/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Wiese Edward A T. ROWE PRICE GROUP, INC. 100 E. PRATT STREET BALTIMORE, MD 21202			Vice President

Signatures
Edward A. Wiese		1/27/2015
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.